|本期目录/Table of Contents|

[1]杨帆,谢树红综述,黄惠娟审校.卵巢癌在代谢组学中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):160-163.[doi:10.3969/j.issn.1672-271X.2018.02.012]
点击复制

卵巢癌在代谢组学中的研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第20卷
期数:
2018年02期
页码:
160-163
栏目:
综述
出版日期:
2018-03-20

文章信息/Info

Title:
-
作者:
杨帆; 谢树红综述; 黄惠娟审校
作者单位：350025福州,厦门大学附属东方医院（南京军区福州总医院）妇产科（杨帆、黄惠娟）;350025福州,南京军区福州总医院妇产科（谢树红）
Author(s):
-
关键词:
卵巢癌;  代谢组学;  肿瘤标志物; 早期诊断; 鉴别诊断
Keywords:
-
分类号:
R711.75
DOI:
10.3969/j.issn.1672-271X.2018.02.012
文献标志码:
A
摘要:
代谢组学是近年来逐渐发展并应用的又一新兴学科，作为一种新的检测工具，对于卵巢癌筛查有重要的临床意义，通过对相关代谢物的分离和鉴定，对卵巢癌的早期诊断、治疗、鉴别及预后有指导作用，文章就代谢组学概念和方法 学、数据分析及卵巢肿瘤标志物筛选、早期诊断、鉴别诊断及预后评估等方面的研究进展进行综述。
Abstract:
-

参考文献/References:

[1]Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[2]Fiehn O. Metabolomics - the link between genotypes and phenotypes[J]. Plant Mol Biol,2002,48(1-2):155-171.
[3]Spratlin JL, Serkova NJ, Eckhardt SG. Clinical Applications of Metabolomics in Oncology: A Review[J]. Clin Cancer Res,2009,15(2):431-440.
[4]Davis VW, Bathe OF, Schiller DE, et al. Metabolomics and Surgical Oncology: Potential Role for Small Molecule Biomarkers[J]. J Surg Oncol,2011,103(5):451-459.
[5]Weiss RH, Kim K. Metabolomics in the study of kidney diseases[J]. Nat Rev Nephrol,2012,8(1):22.
[6]Manach C, Hubert J, Llorach R, et al. The complex links between dietary phytochemicals and human health deciphered by metabolomics[J]. Mol Nutr Food Res,2009,53(10):1303-1315.
[7]Griffiths WJ, Koal T, Wang Y, et al. Targeted metabolomics for biomarker discovery[J]. Mol Nutr Food Res,2010,49(32):5426-5445.
[8]Liu M, Nicholson JK, Lindon JC, et al. High-resolution diffusion and relaxation edited one-and two-dimensional 1H NMR spectroscopy of biological fluids[J]. Anal Chem,1996,68(19):3370-3376.
[9]Davis VW, Bathe OF, Schiller DE, et al. Metabolomics and Surgical Oncology: Potential Role for Small Molecule Biomarkers[J]. J Surg Oncol,2011,103(5):451-459.
[10]Wang JH, Byun J, Pennathur S. Analytical Approaches to Metabolomics and Applications to Systems Biology[J]. Semin Nephrol,2010,30(5):500-511.
[11]Jolliffe IT. Principal Component Analysis[M]. Springer-Verlag,1986,41-64.
[12]Barker M, Rayens W. Partial least squares for discrimination[J]. J Chemometr,2003,17(3):166-173.
[13]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7.
[14]Lyman GH, Bohlke K, Khorana AA, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014[J]. J Clin Oncol,2015,33(6):654-656.
[15]Brooks D, Society AC. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening[J]. CA Cancer J Clin, 2013, 63(2):88-105.
[16]Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer[J]. Mol Cell Proteomics,2004,3(4):355-366.
[17]刘冲, 石群立. 卵巢癌免疫标记物研究进展[J]. 医学研究生学报, 2010, 23(9):985-988.
[18]Nossov V, Amneus M, Su F, et al. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?[J]. Am J Obstet Gynecol,2008,199(3):215-223.
[19]Cesario S. Advances in the early detection of ovarian cancer: How to hear the whispers early[J]. Nurs Womens Health,2010,14(3):222-234.
[20]Zhang Y, Li F, Huang F, et al. Metabolomics analysis reveals variation in Schisandra chinensis cetabolites from different origins[J]. J Sep Sci,2014,37(6):731-737.
[21]Li L, Zhao C, Chang Y, et al. Metabolomics study of cured tobacco using liquid chromatography with mass spectrometry: Method development and its application in investigating the chemical differences of tobacco from three growing regions[J]. J Sep Sci,2014,37(9-10):1067-1074.
[22]Lv M, Chen J, Gao Y, et al. Metabolomics based on liquid chromatography with mass spectrometry reveals the chemical difference in the stems and roots derived from Ephedra sinica[J]. J Sep Sci,2015,38(19):3331-3336.
[23]Zhou M, Guan W, Walker LD, et al. Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy.[J]. Cancer Epidemiol Biomarkers Prev,2010,19(9):2262-2271.
[24]Fong MY, Mcdunn J, Kakar SS. Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer[J]. PLoS One,2011,6:e199635.
[25]Chen J, Zhang X, Cao R, et al. Serum 27-nor-5 beta-Cholestane-3,7,12,24,25 Pentol Glucuronide Discovered by Metabolomics as Potential Diagnostic Biomarker for Epithelium Ovarian Cancer[J]. J Proteome Res,2011,10(5):2625-2632.
[26]Garcia E, Andrews C, Hua J, et al. Diagnosis of Early Stage Ovarian Cancer by H-1 NMR Metabonomics of Serum Explored by Use of a Microflow NMR Probe[J]. J Proteome Res,2011,10(4):1765-1771.
[27]Gaul DA, Mezencev R, Long TQ, et al. Highly-accurate metabolomic detection of early-stage ovarian cancer[J]. Sci Rep,2015,5(16351).
[28]Cheng Y, Li L, Zhu B, et al. Expanded metabolomics approach to profiling endogenous carbohydrates in the serum of ovarian cancer patients[J]. J Sep Sci,2016,39(2):316-323.
[29]Fan L, Zhang W, Yin M, et al. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform[J]. Acta Oncol,2012,51(4):473-479.
[30]Chen J, Zhang X, Cao R, et al. Serum 27-nor-5β-Cholestane-3,7,12,24,25 Pentol Glucuronide Discovered by Metabolomics as Potential Diagnostic Biomarker for Epithelium Ovarian Cancer[J]. J Proteome Res,2011(5):2625-2632.
[31]Chen J, Zhou L, Zhang X, et al. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer[J]. Electrophoresis,2012,33(22):3361-3369.
[32]Ke C, Hou Y, Zhang H, et al. Large-scale profiling of metabolic dysregulation in ovarian cancer[J]. Int J Cancer,2015,136(3):516-526.
[33]Zhang T, Wu X, Yin M, et al. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry[J]. Clin Chim Acta,2012,413(9-10):861-868.
[34]Zhang H, Ge T, Cui X, et al. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling[J]. Mol Biosyst,2015,11(2):516-521.

相似文献/References:

[1]李彩云,龚谋春,潘建虎,等.卵巢癌二次探查手术前PET-CT检查的作用及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):141.
　.Department of Obstetrics and Gynecology.PET-CT Center7 Hospital of PLA,Hangzhou,Zhejiang 00,et al.LI Cai-yun1,GONG Mou-chun1,PAN Jian-hu2[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(02):141.
[2]孙 健,卢 健,邹冬芳,等.结肠腺瘤性息肉病基因异常甲基化在 上皮性卵巢癌中的检测及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):414.
　SUN Jian,LU Jian,ZOU Dong-fang,et al.Significance of hypermethylation of APC in epithelial ovarian carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(02):414.
[3]朱饮源,姚 军,李 曼.糖原合成酶激酶3β对卵巢癌紫杉醇耐药性的影响及机制研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
　ZHU Yin-yuan,YAO Jun,LI Man..The effects of GSK-3β on paclitaxel chemoresistance of ovarian cancer cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(02):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
[4]陈 慧,张 兰,郭以河,等.Eag1钾离子通道在卵巢癌组织中的表达及意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
　CHEN Hui,ZHANG Lan,GUO Yi-he,et al.Expression and significance ofether à go-go 1 channels in human ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(02):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
[5]赵昊云,张承,杨林东综述,等.卵巢癌的脑转移诊疗进展[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):180.[doi:10.3969/j.issn.1672-271X.2016.02.022]
[6]洪丽君,曾清芳,卢昆林,等.高尔基体磷蛋白3在卵巢癌中的表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
　HONG Li-jun,ZENG Qing-fang,LU Kun-lin,et al.Expression and clinical significance of Golgi phosphoprotein 3 in ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(02):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
[7]谢树红,黄惠娟,许玉黎,等.橄榄苦苷对体外卵巢癌SKOV3细胞增殖的影响[J].医学研究与战创伤救治(原医学研究生学报),2018,20(04):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
　XIE Shu-hong,HUANG Hui-juan,XU Yu-li,et al.Effects ofoleuropein on proliferation of ovarian cancer SKOV3 cells in vitro[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
[8]许玉黎,黄惠娟,谢树红,等.橄榄苦苷对卵巢癌裸鼠皮下移植瘤抑瘤作用的研究[J].医学研究与战创伤救治(原医学研究生学报),2018,20(06):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
　XU Yu-li,HUANG Hui-juan,XIE Shu-hong,et al.Study on antitumor effects of oleuropein on ovarian cancer subcutaneous transplanted tumor in nude mice[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
[9]陈娟,刘传丽,陈艳思,等.IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]
　CHENJuan,LIUChuan-li,CHENYan-si,et al.The expression level of IL-17A in ovarian cancer and the bioinformatics analysis of potential mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(02):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]

备注/Memo

备注/Memo:
基金项目：全军医药卫生科研项目（14MS129）
更新日期/Last Update: 2018-03-20